ZYME is currently covered by 7 analysts with average potential upside of $17.01 (87.24%) backed by 29 price targets and 50 ratings. Analyst's average stock valuation to be materialised ratio is 44.73% with an average time for price targets to be met of 142.57 days.
Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 01-Nov-2022.
Highest price target for ZYME is 56, Lowest price target is 5, average price target is 30.5.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
8
$0.16 (2.04%)
40
26 days ago
2/8 (25%)
$18.23 (108.08%)
77
Buy
8
$0.16 (2.04%)
1 months 6 days ago
2/7 (28.57%)
$8.34 (29.29%)
32
Buy
27
$19.16 (244.39%)
28
2 months 29 days ago
5/10 (50%)
$14.15 (138.28%)
242
Buy
45
$37.16 (473.98%)
56
9 months 18 days ago
2/6 (33.33%)
$22.13 (138.43%)
373
Buy
74
$66.16 (843.88%)
74
11 months 17 days ago
3/7 (42.86%)
$25.27 (112.18%)
105
We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important
For each analyst know for every call if it has been before or after the stock price moved
Understand how each analyst reacts to stock price movement
Get Started or Login
